Maryland Oncology Hematolog

Trial Information

A phase II trial of Daratumumab, Lenalidomide and Dexamethasone (DRd) in combination with Selinexor for patients with newly diagnosed multiple myeloma

Learn More at ClinicalTrials.gov

Sponsor: Karyopharm Therapeutics

Disease Types

Multiple Myeloma

Investigator

Narang, Mohit

Sponsor

Karyopharm Therapeutics

« Clinical Trails Main

Phones to our locations

USOR 20285_Karyopharm

Trial Information

Disease Types

Investigator

Sponsor

Quality Care Close to Home

USOR 20285_Karyopharm

Trial Information

Disease Types

Investigator

Sponsor

Quality Care Close to Home

Sign Up Today For Our E-Newsletter